Elevai Labs计划进行逆向股票分割,提高股价,并留在Nasdaq。 Elevai Labs plans a reverse stock split to boost its share price and stay on the Nasdaq.

Elevai Labs Inc.,一家设在加利福尼亚的医疗公司,计划在11月27日进行1对200的逆向股票分割,以满足Nasdaq最低股价1美元的要求。 Elevai Labs Inc., a California-based medical company, plans a 1-for-200 reverse stock split on November 27 to meet Nasdaq's $1.00 minimum share price requirement. 这一行动将把未清股份减少到约307万股,但维持股东股本的总价值。 This action will reduce the number of outstanding shares to about 3.07 million but maintain the total value of shareholders' equity. 此举旨在让Elevai留在Nasdaq资本市场。 The move aims to keep Elevai on the Nasdaq Capital Market.